276 related articles for article (PubMed ID: 12720532)
21. RET/PTC rearrangement in thyroid tumors.
Nikiforov YE
Endocr Pathol; 2002; 13(1):3-16. PubMed ID: 12114746
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant.
Thomas GA; Bunnell H; Cook HA; Williams ED; Nerovnya A; Cherstvoy ED; Tronko ND; Bogdanova TI; Chiappetta G; Viglietto G; Pentimalli F; Salvatore G; Fusco A; Santoro M; Vecchio G
J Clin Endocrinol Metab; 1999 Nov; 84(11):4232-8. PubMed ID: 10566678
[TBL] [Abstract][Full Text] [Related]
23. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus.
Smida J; Salassidis K; Hieber L; Zitzelsberger H; Kellerer AM; Demidchik EP; Negele T; Spelsberg F; Lengfelder E; Werner M; Bauchinger M
Int J Cancer; 1999 Jan; 80(1):32-8. PubMed ID: 9935226
[TBL] [Abstract][Full Text] [Related]
24. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer.
Cheung CC; Carydis B; Ezzat S; Bedard YC; Asa SL
J Clin Endocrinol Metab; 2001 May; 86(5):2187-90. PubMed ID: 11344225
[TBL] [Abstract][Full Text] [Related]
25. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas.
Lee CH; Hsu LS; Chi CW; Chen GD; Yang AH; Chen JY
J Clin Endocrinol Metab; 1998 May; 83(5):1629-32. PubMed ID: 9589668
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of papillary thyroid carcinoma is facilitated by using an RT-PCR approach on laser-microdissected archival material to detect RET oncogene activation.
Lahr G; Stich M; Schütze K; Blümel P; Pösl H; Nathrath WB
Pathobiology; 2000; 68(4-5):218-26. PubMed ID: 11279350
[TBL] [Abstract][Full Text] [Related]
27. Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome.
Kjellman P; Learoyd DL; Messina M; Weber G; Höög A; Wallin G; Larsson C; Robinson BG; Zedenius J
Br J Surg; 2001 Apr; 88(4):557-63. PubMed ID: 11298625
[TBL] [Abstract][Full Text] [Related]
28. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR.
Sheils OM; O'Leary JJ; Sweeney EC
J Pathol; 2000 Sep; 192(1):32-6. PubMed ID: 10951397
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas.
Lam KY; Lo CY; Leung PS
Eur J Endocrinol; 2002 Dec; 147(6):741-5. PubMed ID: 12457448
[TBL] [Abstract][Full Text] [Related]
30. RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).
Nakazawa T; Kondo T; Kobayashi Y; Takamura N; Murata S; Kameyama K; Muramatsu A; Ito K; Kobayashi M; Katoh R
Cancer; 2005 Sep; 104(5):943-51. PubMed ID: 16015630
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma.
Musholt TJ; Musholt PB; Khaladj N; Schulz D; Scheumann GF; Klempnauer J
Surgery; 2000 Dec; 128(6):984-93. PubMed ID: 11114633
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia.
Chua EL; Wu WM; Tran KT; McCarthy SW; Lauer CS; Dubourdieu D; Packham N; O'Brien CJ; Turtle JR; Dong Q
J Clin Endocrinol Metab; 2000 Aug; 85(8):2733-9. PubMed ID: 10946873
[TBL] [Abstract][Full Text] [Related]
33. Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma.
Dinets A; Hulchiy M; Sofiadis A; Ghaderi M; Höög A; Larsson C; Zedenius J
Eur J Endocrinol; 2012 Jun; 166(6):1049-60. PubMed ID: 22457234
[TBL] [Abstract][Full Text] [Related]
34. RET activation and clinicopathologic features in poorly differentiated thyroid tumors.
Santoro M; Papotti M; Chiappetta G; Garcia-Rostan G; Volante M; Johnson C; Camp RL; Pentimalli F; Monaco C; Herrero A; Carcangiu ML; Fusco A; Tallini G
J Clin Endocrinol Metab; 2002 Jan; 87(1):370-9. PubMed ID: 11788678
[TBL] [Abstract][Full Text] [Related]
35. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.
Nikiforov YE; Rowland JM; Bove KE; Monforte-Munoz H; Fagin JA
Cancer Res; 1997 May; 57(9):1690-4. PubMed ID: 9135009
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.
Zhu Z; Ciampi R; Nikiforova MN; Gandhi M; Nikiforov YE
J Clin Endocrinol Metab; 2006 Sep; 91(9):3603-10. PubMed ID: 16772343
[TBL] [Abstract][Full Text] [Related]
37. RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas?
Musholt PB; Imkamp F; von Wasielewski R; Schmid KW; Musholt TJ
Surgery; 2003 Dec; 134(6):881-9; discussion 889. PubMed ID: 14668719
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation.
Bounacer A; Wicker R; Caillou B; Cailleux AF; Sarasin A; Schlumberger M; Suárez HG
Oncogene; 1997 Sep; 15(11):1263-73. PubMed ID: 9315093
[TBL] [Abstract][Full Text] [Related]
39. Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.
Mayr B; Pötter E; Goretzki P; Rüschoff J; Dietmaier W; Hoang-Vu C; Dralle H; Brabant G
Br J Cancer; 1998 Mar; 77(6):903-6. PubMed ID: 9528832
[TBL] [Abstract][Full Text] [Related]
40. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]